Aldeyra Therapeutics
ALDX
ALDX
77 hedge funds and large institutions have $141M invested in Aldeyra Therapeutics in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
43% less capital invested
Capital invested by funds: $249M → $141M (-$107M)
48% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 23
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
77
Holding in Top 10
1
Calls
$436K
Puts
$86K
Top Buyers
| 1 | +$4.17M | |
| 2 | +$3.36M | |
| 3 | +$1.28M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.26M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$1.25M |
Top Sellers
| 1 | -$8.42M | |
| 2 | -$2.76M | |
| 3 | -$2.76M | |
| 4 |
Millennium Management
New York
|
-$2.4M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2M |